Accelerating Clinical Trials: How Cloudbyz eClinical Solutions Address the Urgent Need for IT Modernization in Biopharma

The McKinsey article “Faster, Smarter Trials: Modernizing Biopharma’s R&D IT Applications” highlights a critical issue in clinical research—outdated, fragmented IT infrastructures that hinder the speed, efficiency, and success of clinical trials. The report emphasizes that while AI and digital technologies hold immense promise, their full potential can only be realized with modernized, integrated clinical development applications.

At Cloudbyz, we recognize this challenge and have built our unified eClinical platform to address these very pain points. By offering a natively integrated solution on Salesforce, Cloudbyz provides a seamless, real-time, and AI-powered clinical development ecosystem that directly tackles the inefficiencies outlined in the McKinsey report.

Here’s how Cloudbyz eClinical is the answer to the challenges and opportunities presented in this report.

The Challenge: Outdated Clinical Development Applications are a Bottleneck

According to the McKinsey report, biopharma R&D productivity is declining due to increasing clinical trial costs, long study durations, and decreasing success rates. Legacy IT infrastructures contribute significantly to these inefficiencies due to:

• Siloed data and disconnected workflows, making real-time insights and seamless data exchange difficult.
• Ineffective AI adoption, as outdated applications fail to support next-gen analytics for trial planning, risk modeling, and resource optimization.
• Slow trial start-up and execution, with rigid, manual processes delaying site selection, activation, and data capture.
• Fragmented vendor ecosystems, where point solutions create integration challenges and lead to higher IT maintenance costs.

McKinsey’s research estimates that modernizing clinical development IT could:

• Accelerate study start-up by 15-20%
• Reduce trial length by 15-30%
• Improve productivity by 15-30%
• Increase success rates by 10% through better patient identification

The message is clear: modernizing IT applications is no longer optional but a necessity.

The Cloudbyz Solution: A Unified, Next-Gen eClinical Platform

Cloudbyz eClinical suite was designed from the ground up to eliminate the inefficiencies of legacy systems and enable AI-driven clinical operations at scale. Our solutions align directly with McKinsey’s recommendations by providing a fully integrated, cloud-native clinical trial technology stack.

1. End-to-End Integration for Faster Trial Execution

McKinsey stresses the importance of seamless data integration across CTMS, eTMF, EDC, RTSM, eCOA, and Pharmacovigilance systems. Cloudbyz delivers exactly that—a unified platform that connects all critical clinical trial functions within a single ecosystem.

Our platform enables:

• Real-time data capture and monitoring, ensuring immediate access to trial insights.
• Automated workflows for site selection, study activation, and document exchange, accelerating trial start-up and reducing administrative burden.
• AI-driven predictive analytics for site feasibility, enrollment forecasting, and risk-based monitoring.

✔ Outcome: Sponsors and CROs using Cloudbyz CTMS and eTMF solutions report up to 30% faster study start-up and 20% reduction in manual workload.

2. AI-Enabled Trial Optimization for Higher Productivity

The report highlights how AI and generative AI can unlock over $50 billion annually across clinical R&D but warns that outdated IT applications limit its effectiveness.

Cloudbyz embraces AI and advanced analytics with:

• AI-driven risk-based monitoring, allowing sponsors to detect and mitigate trial risks proactively.
• Automated metadata extraction and document classification in eTMF, reducing regulatory delays.
• Intelligent patient matching and recruitment algorithms, ensuring faster enrollment with diverse populations.
• Predictive site performance analytics, helping sponsors select the best-performing trial sites.

✔ Outcome: Cloudbyz customers experience a 15-30% increase in clinical operations productivity and fewer protocol deviations through data-driven decision-making.

3. A Scalable, Cloud-Native Infrastructure for Future-Ready Trials

McKinsey identifies that many pharma companies struggle with scaling their modernization efforts due to fragmented solutions and technical debt.

Cloudbyz eliminates these roadblocks with:

• A natively built Salesforce-based platform, ensuring scalability, flexibility, and security.
• Single-source-of-truth architecture, reducing IT maintenance costs by 20-30%.
• Configurable workflows tailored to the specific needs of sponsors, CROs, and sites.
• Seamless interoperability with external databases, EHRs, and real-world data sources.

✔ Outcome: Cloudbyz’s fully cloud-based ecosystem reduces IT burden, improves compliance, and ensures seamless scalability for global trials.

4. Enabling Decentralized and Patient-Centric Trials

The report emphasizes that decentralized trials (DCTs) are the future—but legacy IT systems are not designed to support them.

Cloudbyz facilitates decentralized and hybrid trials by:

• Enabling remote patient monitoring, eConsent, and virtual site visits.
• Integrating with eCOA/ePRO for real-world patient data collection.
• Providing AI-driven site support tools, reducing site workload and improving patient engagement.

✔ Outcome: Cloudbyz customers adopting decentralized trial capabilities accelerate patient recruitment by 20% and improve patient retention rates.

5. Reducing Clinical IT Costs and Increasing ROI

McKinsey found that companies investing in modernization have yet to achieve a clear ROI due to scattered modernization efforts.

Cloudbyz provides a structured, ROI-driven modernization approach by:

• Replacing multiple point solutions with a single, unified platform.
• Reducing IT overhead and maintenance costs through cloud automation.
• Optimizing clinical operations efficiency through real-time analytics and AI.

✔ Outcome: Cloudbyz customers experience a 20-30% reduction in IT costs while achieving faster, more efficient trials.

Conclusion: Cloudbyz eClinical is the Future of Clinical Trial IT Modernization

McKinsey’s report makes it clear: biopharma companies that fail to modernize their clinical IT stack will struggle to keep pace with industry advancements. However, modernization must be approached strategically, with a focus on integration, scalability, and AI-readiness.

Cloudbyz eClinical is the answer to this urgent need—a fully unified, cloud-native, and AI-powered platform that accelerates study start-up, enhances data integration, improves trial success rates, and drives operational excellence in clinical research.

If you are a biopharma leader looking to modernize your clinical IT infrastructure, Cloudbyz offers the fastest path to digital transformation—helping you conduct trials smarter, faster, and more efficiently than ever before.

Ready to Future-Proof Your Clinical Trials?

Explore Cloudbyz eClinical today and unlock the full potential of AI-driven, modernized clinical research. Contact us for a personalized demo and see how we can transform your clinical operations.